Patent

[SpicyIP Tidbit] Patent’s Gone, War’s On: Inside Novo Nordisk’s Semaglutide Litigation Blitz

Yesterday, Khushi and I wrote on the Semaglutide patent expiry and what it could mean for Indian generic companies and the general public. And while the market is seeing more affordable versions of the drug, a separate story is taking place in the Delhi High Court with Novo Nordisk filing a fresh set of trademark and patent infringement suits against generic companies.  The Ozempic Name Game: Novo Nordisk v. DRL Round 2 On Semaglutide injections, Novo Nordisk has filed a […]

[SpicyIP Tidbit] Patent’s Gone, War’s On: Inside Novo Nordisk’s Semaglutide Litigation Blitz Read More »

Wonder Drug, Generic Price: What Semaglutide’s Patent Expiry Should Really Mean for India

[This post is co-authored with Khushi Krishania. Khushi is a third-year B.Sc. LL.B. (Hons.) {Cybersecurity} student at the National Law Institute University, Bhopal, with a particular interest in the intersection of copyright and data protection law.] Christmas came early for Indian generic manufacturers as the Indian patent on Semaglutide, a potent GLP-1 receptor agonist, expired on March 20. The drug is commercially sold by Novo Nordisk as Ozempic and Wegovy and is used to manage type-2 diabetes and obesity. After

Wonder Drug, Generic Price: What Semaglutide’s Patent Expiry Should Really Mean for India Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 16 – March 22)

(This week’s review is authored by Shubham Thakare. Shubham is currently an intern with SpicyIP. He is a third-year B.A., LL.B. (Hons.) student at the National Law School of India University, Bengaluru, with an interest in copyright and trademark law.) As we move further into March, this week’s review brings into focus questions around the limits of IP protection over identity, alongside a series of significant judicial developments across trademarks, patents, and copyright. From clarifying the misplaced claim of copyright

SpicyIP Weekly Review (March 16 – March 22) Read More »

TWN- IUCIPRS Workshop on Patent Opposition in Pharmaceutical Field (Apply by 31 March)

Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are organising the 7th edition of their workshop titled ‘Patent Opposition in the Pharmaceutical Field’ from 28 May- 1 June, 2026. Last date to apply is 31 March, 2026. Read on below for their announcement. TWN- IUCIPRS Workshop on Patent Opposition in Pharmaceutical Field (Apply by 31 March) Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are collaboratively organising the seventh edition of the workshop titled ‘Patent Opposition in

TWN- IUCIPRS Workshop on Patent Opposition in Pharmaceutical Field (Apply by 31 March) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 9 – March 15)

Midway through March, we approach the colourful spring with a post on Pantone’s latest choice for its annual colour of the year! Another post on understanding fair dealing as a component of the copyright system and not the central axis. Can the Patent Office reject a patent application on one ground and decline to analyse the rest in the name of efficiency? Post discussing Bombay High Court’s ruling in JFE Steel Corporation v. Controller of Patents & Designs. Case summaries

SpicyIP Weekly Review (March 9 – March 15) Read More »

Sufficiency of Disclosure and Patent Rejections

Can the Patent Office reject a patent application on one ground and decline to analyse the rest in the name of efficiency? Using the Bombay High Court’s ruling in [Edit: fixed an error in the case name] JFE Steel Corporation v. The Assistant Controller of Patents & Designs, Priyam explores the limits of judicial economy in rejection orders, along with issues relating to insufficient disclosure and foreign prosecution history. Priyam is a 3rd-year student at the National Law School of India

Sufficiency of Disclosure and Patent Rejections Read More »

India’s Defining Moment on SEPs: The Supreme Court’s Decision Opens the Door for Policy Leadership

The Supreme Court’s disposal of CCI v. Ericsson has triggered significant debate over the respective roles of patent law and competition law in regulating SEPs. Brian Scarpelli explains how this decision creates a crucial policy moment for India to clarify the role of its legal framework in addressing anticompetitive SEP licensing practices. Brian Scarpelli is Senior Global Policy Counsel at ACT | The App Association, where he works on a diversity of legal and policy issues impacting mobile app development

India’s Defining Moment on SEPs: The Supreme Court’s Decision Opens the Door for Policy Leadership Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 2 – March 8)

Applications are now open for the second iteration of the SpicyIP Summer School 2026! 1st National Policy Brief Competition on IP and Innovation 2025 successfully organised by SpicyIP and CIPAM, DPIIT. Can a dead patent be revoked? Post on the Delhi HC’s DB judgment in Boehringer Ingelheim v. Controller of Patents. Case summaries and IP developments from the country and the globe and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment

SpicyIP Weekly Review (March 2 – March 8) Read More »

(Part II) So Open, Yet So Overlooked: A Dive into the World of FOSS

In the first part of the post, I explained the emergence of FOSS and its effect on innovation – often accelerating it but with its own bumps along the road. This part will wheel the discussion to another thorny issue: patentability of software and the many new questions it raises, both generally and in the India context.  When Code Slips through Copyright A pertinent question to be considered, before detailing the Indian standpoint, is – how does IPR enter the

(Part II) So Open, Yet So Overlooked: A Dive into the World of FOSS Read More »

Thinking Out Loud……Literally: Brains And Boundaries

The rise of brain–computer interfaces marks a technological inflection point, blurring the line between cognition and computation. What happens when thoughts become data, and data becomes patentable subject matter? Soumya Juneja, in her post for the SpicyIP–Jhana Blogpost Writing Competition 2025, engages with these questions and assesses whether there is a need to re-examine invention, prior art, and authorship in the age of neurotechnology. Soumya Juneja is an Associate at an IP law firm and a BBA.LLB. (Hons.) graduate from

Thinking Out Loud……Literally: Brains And Boundaries Read More »

Scroll to Top